Exact Mass: 430.3235482
Exact Mass Matches: 430.3235482
Found 500 metabolites which its exact mass value is equals to given mass value 430.3235482,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ruscogenin
Ruscogenin is a triterpenoid. Ruscogenin is a natural product found in Cordyline rubra, Cordyline banksii, and other organisms with data available. Ruscogenin, an important steroid sapogenin derived from Ophiopogon japonicus, attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Ruscogenin exerts significant anti-inflammatory and anti-thrombotic activities. Ruscogenin has orally bioactivity[1][2]. Ruscogenin, an important steroid sapogenin derived from Ophiopogon japonicus, attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Ruscogenin exerts significant anti-inflammatory and anti-thrombotic activities. Ruscogenin has orally bioactivity[1][2].
Hocogenin
Hecogenin is a triterpenoid. Hecogenin is a natural product found in Yucca gloriosa, Allium rotundum, and other organisms with data available.
Australigenin
Sapogenin from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the US
(22R,23R)-22,23-dihydroxy-campest-4-en-3-one
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-HOCA)
7alpha-Hydroxy-3-oxo-4-cholestenoate, also known as 7-Hoca, is a member of the class of compounds known as monohydroxy bile acids, alcohols, and derivatives. Thes compounds are bile acids, alcohols, or any of their derivatives bearing a hydroxyl group. 7alpha-Hydroxy-3-oxo-4-cholestenoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 7alpha-Hydroxy-3-oxo-4-cholestenoate is involved in metabolic disorders such as 27-hydroxylase deficiency, familial hypercholanemia (FHCA), and Zellweger syndrome. 7alpha-Hydroxy-3-oxo-4-cholestenoate is involved in the primary bile acid biosynthesis pathway. 7alpha-Hydroxy-3-oxo-4-cholestenoate is created from either 3beta,7alpha-dihydroxy-5-cholestenoate or 7alpha,26-dihydroxy-4-cholesten-3-one through the actions of HSD3B7 (EC 1.1.1.181) or CYP27A (EC 1.14.13.15), respectively.
Barogenin
Cryptogenin is a constituent of Balanites aegyptiaca (soapberry tree fruits) Constituent of Balanites aegyptiaca (soapberry tree fruits).
4,4-Diapo-psi,psi-carotene-4-oic acid
Sorbitan stearate
Sorbitan stearate is a food emulsifier, stabiliser, defoaming agent, flavouring and flavour modifier, rehydration agent for active dried yeast, coating for fruit and vegetables and other food uses Sorbitan monostearate (also known as Span 60) is an ester of sorbitan (a sorbitol derivative) and stearic acid and is sometimes referred to as a synthetic wax. It is primarily used as an emulsifier to keep water and oils mixed. Sorbitan monostearate is used in the manufacture of food and healthcare products, and is a non-ionic surfactant with emulsifying, dispersing, and wetting properties Food emulsifier, stabiliser, defoaming agent, flavouring and flavour modifier, rehydration agent for active dried yeast, coating for fruit and vegetables and other food uses
Schleicherastatin 6
Schleicherastatin 7 is found in fruits. Schleicherastatin 7 is a constituent of the famine food Schleichera oleosa
Sintaxanthin
Isolated from the exocarp of Sinton citrangequat (a Citrus/Poncirus/Fortunella hybrid). Sintaxanthin is found in sweet orange and citrus. Sintaxanthin is found in citrus. Sintaxanthin is isolated from the exocarp of Sinton citrangequat (a Citrus/Poncirus/Fortunella hybrid
24-Oxo-1alpha,25-dihydroxyvitamin D3
This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.
(2beta,3alpha,9alpha,24R)-Ergosta-7,22-diene-2,3,9-triol
(2beta,3alpha,9alpha,24R)-Ergosta-7,22-diene-2,3,9-triol is found in mushrooms. (2beta,3alpha,9alpha,24R)-Ergosta-7,22-diene-2,3,9-triol is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). (2beta,3alpha,9alpha,24R)-Ergosta-7,22-diene-2,3,9-triol is found in mushrooms.
(3beta,5beta,8beta,22E,24xi)-Ergosta-6,22-diene-3,5,8-triol
(3beta,5beta,8beta,22E,24xi)-Ergosta-6,22-diene-3,5,8-triol is found in mushrooms. (3beta,5beta,8beta,22E,24xi)-Ergosta-6,22-diene-3,5,8-triol is a constituent of Gyroporus castaneus (chestnut bolete). Constituent of Gyroporus castaneus (chestnut bolete). (3beta,5beta,8beta,22E,24xi)-Ergosta-6,22-diene-3,5,8-triol is found in mushrooms.
Schidigeragenin C
Genin from Yucca schidigera (Mojave yucca). Schidigeragenin C is found in fruits. Schidigeragenin C is found in fruits. Genin from Yucca schidigera (Mojave yucca
MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0)
MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. [HMDB] MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.
4alpha-Carboxy-5alpha-cholesta-8-en-3beta-ol
4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol is a 3-beta-hydroxysterol that is an intermediate in cholesterol biosynthesis II (via 24,25-dihydrolanosterol). It is a substrate for NAD(P)-dependent steroid dehydrogenase (H105E3) and it can be generated from the enzymatic carboxylation of 5alpha-cholesta-8-en-3-one. It is also a substrate for C-4 methyl sterol oxidase (SC4MOL) and can be generated from the enzymatic oxidation of 4alpha-formyl-5alpha-cholesta-8-en-3beta-ol. The sequence of reactions and the types of intermediates in cholesterol biosynthesis may vary. Alternate routes exist because reduction of the carbon 24,25 double bond on the hydrocarbon side chain of the sterol ring structure by sterol delta24-reductase can occur at multiple points in the pathway, giving rise to different intermediates. These intermediates, with or without a double bond in the hydrocarbon side chain, can serve as substrates for the other enzymes in the pathway. [HMDB] 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol is a 3-beta-hydroxysterol that is an intermediate in cholesterol biosynthesis II (via 24,25-dihydrolanosterol). It is a substrate for NAD(P)-dependent steroid dehydrogenase (H105E3) and it can be generated from the enzymatic carboxylation of 5alpha-cholesta-8-en-3-one. It is also a substrate for C-4 methyl sterol oxidase (SC4MOL) and can be generated from the enzymatic oxidation of 4alpha-formyl-5alpha-cholesta-8-en-3beta-ol. The sequence of reactions and the types of intermediates in cholesterol biosynthesis may vary. Alternate routes exist because reduction of the carbon 24,25 double bond on the hydrocarbon side chain of the sterol ring structure by sterol delta24-reductase can occur at multiple points in the pathway, giving rise to different intermediates. These intermediates, with or without a double bond in the hydrocarbon side chain, can serve as substrates for the other enzymes in the pathway.
25-Hydroxyvitamin D3-26,23-lactol
This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.
4α-carboxy-5α-cholesta-8-en-3β-ol
4α-carboxy-5α-cholesta-8-en-3β-ol is also known as 4alpha-Carboxy-5alpha-cholest-8-en-3beta-ol. 4α-carboxy-5α-cholesta-8-en-3β-ol is considered to be practically insoluble (in water) and acidic. 4α-carboxy-5α-cholesta-8-en-3β-ol is a sterol lipid molecule
(25R)-3beta-hydroxycholest-5-en-7-one-26-oate
(25R)-3beta-hydroxycholest-5-en-7-one-26-oate is also known as (3beta,25R)-3-Hydroxy-7-oxocholest-5-en-26-Oate. (25R)-3beta-hydroxycholest-5-en-7-one-26-oate is considered to be practically insoluble (in water) and acidic
N-Eicosapentaenoyl Glutamine
N-eicosapentaenoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Eicosapentaenoyl Lysine
C26H42N2O3 (430.31952620000004)
N-eicosapentaenoyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Lysine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Cholesterol carbonate
Urea, N'-(2,4-difluorophenyl)-N-((4-(2,2-dimethylpropyl)phenyl)methyl)-N-heptyl-
Ruscogenin
MG(PGF1alpha/0:0/0:0)
MG(PGF1alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/PGF1alpha/0:0)
MG(0:0/PGF1alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
DG(2:0/18:1(12Z)-2OH(9,10)/0:0)
DG(2:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:1(12Z)-2OH(9,10)/2:0/0:0)
DG(18:1(12Z)-2OH(9,10)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/18:1(12Z)-2OH(9,10))
DG(2:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:1(12Z)-2OH(9,10)/0:0/2:0)
DG(18:1(12Z)-2OH(9,10)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Nuatigenin
Nuatigenin belongs to furospirostanes and derivatives class of compounds. Those are heterocyclic steroids containing a furospirostane moiety, which a skeleton characterized by the presence of a 1,6-dioxaspiro[4.4]nonane ring system and an androstane moiety. Nuatigenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Nuatigenin can be found in oat, which makes nuatigenin a potential biomarker for the consumption of this food product.
Kuguacin E
Kuguacin e is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Kuguacin e can be found in bitter gourd, which makes kuguacin e a potential biomarker for the consumption of this food product.
Yuccagenin
Yuccagenin is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Yuccagenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Yuccagenin can be found in fenugreek, which makes yuccagenin a potential biomarker for the consumption of this food product.
(22R,23R)-22,23-dihydroxy-campest-4-en-3-one
(22r,23r)-22,23-dihydroxy-campest-4-en-3-one belongs to dihydroxy bile acids, alcohols and derivatives class of compounds. Those are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups (22r,23r)-22,23-dihydroxy-campest-4-en-3-one is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (22r,23r)-22,23-dihydroxy-campest-4-en-3-one can be found in a number of food items such as black radish, chinese water chestnut, arrowroot, and lemon grass, which makes (22r,23r)-22,23-dihydroxy-campest-4-en-3-one a potential biomarker for the consumption of these food products.
Cerevisterol
An ergostanoid that is (22E)-ergosta-7,22-diene substituted by hydroxy groups at positions 3, 5 and 6 (the 3beta,5alpha,6beta stereoisomer). It has been isolated from the fungus, Xylaria species. Cerevisterol is a steroid isolated from the fruiting bodies of Agaricus blazei[1]. Cerevisterol is a steroid isolated from the fruiting bodies of Agaricus blazei[1].
Laurebiphenyl
A sesquiterpenoid that is a dimer of a cyclolaurane type sesquiterpene. Isolated from the marine red algae Laurencia nidifica and Laurencia tristicha, it exhibits antineoplastic activity.
Cryptogenin
4-(3-ACO-10,13-DI-ME-1H-CYCLOPENTA(A)PHENANTHREN-17-YL)-PENTANOIC ACID ME ESTER
3beta,6alpha,20xi-Trihydroxy-5alpha-cholesta-9(11),24-dien-23-on|3beta,6alpha,20xi-trihydroxy-5alpha-cholesta-9(11),24-dien-23-one
Cyclomicrophyllin B|Cyclomicrophyllin-B|Cyclomicrophylline-B
C27H46N2O2 (430.35590959999996)
(3beta,5beta,6beta)-5,6-epoxyergost-24(28)-ene-3,19-diol|(3beta,5beta,6beta)-5,6-epoxyergost-24(28)-ene-3beta,19-diol|5,6-epoxylitosterol|5beta,6beta-Epoxide-Ergosta-5,24(28)-diene-3,19-diol
(22E,24S)-24-methylcholesta-7,22-diene-3beta,5alpha,6beta,9alpha-tetrol
24-Methylcholesta-9(11),24(28)-diene-3??,12??,19-triol
(5alpha,12beta,25R)-12-Hydroxyspirostan-3-one|Hispidogenin
24-methylenecholest-7-en-3beta,5alpha,6beta-triol|ergosta-7,24(28)-diene-3beta,5alpha,6beta-triol
(20S,22E)-cholesta-1,22-diene-16beta,18,20-triol-3-one
5beta,6beta-epoxyergost-24(28)-ene-3beta,7beta-diol
(5alpha,12alpha,25S)-12-Hydroxyspirostan-3-one|Torvogenin
3beta,5-Dihydroxy-5alpha-ergost-7-en-6-on|3beta,5-dihydroxy-5alpha-ergost-7-en-6-one|3beta,5alpha-dihydroxyergost-7-en-6-one|3??,5??-Dihydroxyergost-7-en-6-one
24xi-hydroperoxy-6beta-hydroxycholesta-4,25-dien-3-one
Cyclomicophyllin-C|Cyclomicrophyllin C|Cyclomicrophyllin-C|Cyclomicrophylline-C
C27H46N2O2 (430.35590959999996)
3beta,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one|3beta,11-dihydroxy-24-methylene-9,11-secocholestan-5-en-9-one|3beta-3,11-Dihydroxy-9,11-secoergosta-5,24(28)-dien-9-one|8betaH-3beta,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one
25,26,27-trisnor-3alpha-methoxy-lanost-9(11)-en-24-oic acid
12alpha,24alpha-dihydroxy-20,24-dimethyl-25-norscalar-17-ene-18,24-carbolactone|phyllolactone E
(3beta,4beta,22R)-ergosta-5,24(24)-diene-3,4,22-triol
5,8-epidioxy-5alpha,8alpha-ergost-22t-en-3beta-ol|5alpha,6alpha-epidioxyergost-6-en-3beta-ol|5alpha,8alpha-epidioxy-24(R)-methylcholesta-6,22-dien-3beta-ol|ergosterol peroxide
24-methylcholesta-5,24(28)-diene-3beta,15beta,19-triol
(7R*,8R*)-6-hydroxy-2,8-dimethyl-2-((3E)-4,8,12-trimethyl-7,8-dihydroxytrideca-3,11-dien-1-yl)chroman|(7R*,8R*)-6-hydroxy-2,8-dimethyl-2-<(3E)-4,8,12-trimethyl-7,8-dihydroxytrideca-3,11-dien-1-yl>chroman
3alpha-hydroxy-21alpha-methoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
(24R)-3beta,11-dihydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one|leptosterol A
25,26,27-trinor-3alpha-methoxycycloartan-24-oic acid
24,25,26,27-tetranor-3beta-acetoxycycloartan-23-ol
3beta,9alpha-dihydroxycholest-7-en-6,23-dione|grandol D
16,22-epoxy-20beta,23S-dihydroxycholest-1-ene-3-one
(24S,22E)-3beta,5alpha-dihydroxyergost-22-en-6-one
23alpha-hydroxy-3-oxo-25,26,27-trinordammar-24,20alpha-olide
(3beta,4beta,7alpha)-ergosta-5,24(28)-diene-3,4,7-triol|(3S,4R,7S,8S,9S,10R,13R,14S,17R)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-10,13-dimethyl-17-[ (2R)-6-methyl-5-methylideneheptan-2-yl]-1H-cyclopenta[a]phenanthrene-3,4,7-triol
(25R)-Spirost-4-en-2alpha,3beta-diol|(25R)-spirost-4-ene-2alpha,3beta-diol|yuccagenin
(3S,5Z,7E)-3,23,25-Trihydroxy-9,10-secocholesta-5,7,10(19)-trien-24-one
(24R)-5alpha,8alpha-epidioxyergosta-6-en-3beta-ol|5,8-epidioxy-24-methylcholesta-6-en-3beta-ol|5,8-epidioxy-5alpha,8alpha-ergost-6-en-3beta-ol|5alpha,8alpha-epi-dioxy-(24S)-ergost-6-en-3beta-ol|5alpha,8alpha-epidioxy-(24S)-ergost-6-en-3beta-ol|5alpha,8alpha-epidioxy-24(S)-methylcholest-6-en-3beta-ol
17alpha-hydroxy-22,23-epoxy-24-methylcholest-5-en-3beta-ol
25-hydroperoxy-6beta-hydroxycholesta-4,23-dien-3-one
(3beta,4beta)-ergosta-5,24(28)-diene-3,4,20-triol|ergosta-5,24(24)-diene-3beta,4beta,20beta-triol
24-methylenecholest-5-en-1alpha,3beta,11alpha-triol|24-methylenecholest-5-ene-1alpha-3beta,11alpha-triol
(22E)-24-methylcholesta-5,22-diene-1alpha,3beta,7alpha-triol
cholesta-1,4-dien-12beta,16beta,20alpha-triol-3-one
13-oxo-22-phenyl-docosanoic acid|13-Oxo-22-phenyl-docosansaeure
(3beta)-25,26,27-trinorcucurbita-5,24-diene-7,23-dione-3,29-diol|balsaminol D
24(,28-Epoxide-(3beta,7alpha)-Ergosta-5,24(28)-diene-3,7-diol|24xi,28-Epoxide-(3beta,7alpha)-ergosta-5,24(28)-diene-3,7-diol
3beta,7alpha,20beta-Trihydroxyergosta-5,24(24)-diene
gammar-Lactone-(3S,5E,7E,10S)-3,23,25-Trihydroxy-9,10-secocholesta-5,7-dien-26-oic acid
1,2-Dihydro-(16beta,22E)-16,18,20-Trihydroxycholesta-1,4,22-trien-3-one
3beta-hydroxy-5alpha,6alpha-epoxy-9-oxo-9,11-seco-5alpha-cholest-7-en-11-al
24(R)-methylcholesta-5,22-diene-1alpha,3beta,11alpha-triol
24-methylenecholesta-5-en-1alpha,3beta,7beta-triol|sinugrandisterol A
(22E)-6beta-methoxy-5alpha-cholesta-7,22-diene-3beta,5-diol
Epipachysamin-C-diacetat|N,N-Diacetylepipachysamine C
C27H46N2O2 (430.35590959999996)
(2E,6E)-2-(10(S),11(S)-dihydroxygeranylgeranyl)-6-methylquinol|2-(10,11-Dihydroxygeranylgeranyl)-6-methyl-1,4-benzenediol
2alpha,11-dihydroxy-9,11-seco-cholest-4,7-dien-6,9-dione
(1S,23R,5Z,7E)-1,3,25-Trihydroxy-9,10-secocholesta-5,7,10(19)-trien-23-one
1,2-Dihydro,27-nor-(16beta,22E)-16,18,20-Trihydroxy-24-methylcholesta-1,4,22-trien-3-one
(25RS)-Ruscogenin
Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su
Pennogenin
Pennogenin is an oxaspiro compound that is spirost-5-en substituted by hydroxy groups at positions 3 and 17 (3beta,25R stereoisomer). It has a role as a metabolite. It is a 17alpha-hydroxy steroid, an oxaspiro compound, an organic heterohexacyclic compound, a sapogenin and a 3beta-hydroxy-Delta(5)-steroid. It derives from a hydride of a spirostan. Pennogenin is a natural product found in Paris polyphylla var. chinensis, Polygonatum stenophyllum, and other organisms with data available. An oxaspiro compound that is spirost-5-en substituted by hydroxy groups at positions 3 and 17 (3beta,25R stereoisomer).
Sorbitane Monostearate - Polysorbate 60 in-source fragment
C27H42O4_(3beta,5alpha,8xi,9xi,14xi,25S)-3-Hydroxyspirostan-12-one
Gly Lys Lys Val
Gly Lys Val Lys
Gly Val Lys Lys
Ile Ile Ser Val
Ile Ile Val Ser
Ile Leu Ser Val
Ile Leu Val Ser
Ile Ser Ile Val
Ile Ser Leu Val
Ile Ser Val Ile
Ile Ser Val Leu
Ile Thr Val Val
Ile Val Ile Ser
Ile Val Leu Ser
Ile Val Ser Ile
Ile Val Ser Leu
Ile Val Thr Val
Ile Val Val Thr
Lys Gly Lys Val
Lys Gly Val Lys
Lys Lys Gly Val
Lys Lys Val Gly
Lys Val Gly Lys
Lys Val Lys Gly
Leu Ile Ser Val
Leu Ile Val Ser
Leu Leu Ser Val
Leu Leu Val Ser
Leu Ser Ile Val
Leu Ser Leu Val
Leu Ser Val Ile
Val Gly Lys Lys
Val Lys Gly Lys
Val Lys Lys Gly
3beta-Hydroxy-5alpha,6alpha-epoxy-9-oxo-9,10-seco-5-cholest-7-en-11-al
(5Z,7E)-(1S,3R,24R,25R)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24R,25S)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24S,25R)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24S,25S)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
1α,25-dihydroxy-24-oxovitamin D3 / 1α,25-dihydroxy-24-oxocholecalciferol
(23S)-23,25-dihydroxy-24-oxovitamin D3 / (23S)-23,25-dihydroxy-24-oxocholecalciferol
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol / (23S,25R)-25-hydroxycholecalciferol 26,23-lactol
(5Z,7E,22E)-(1S,3R,24R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24,25-tetrol
(5Z,7E,22E)-(1S,3R,24S)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24,25-tetrol
(5Z,7E,22E)-(1S,3R,25R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25,26-tetrol
(5Z,7E,22E)-(1S,3R,25S)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25,26-tetrol
1α-hydroxy-25-methoxyvitamin D3 / 1α-hydroxy-25-methoxycholecalciferol
25-methyl-1α,26-dihydroxyvitamin D3 / 25-methyl-1α,26-dihydroxycholecalciferol
(1R)-25-hydroxy-1-(hydroxymethyl)vitamin D3 / (1R)-25-hydroxy-1-(hydroxymethyl)cholecalciferol
(1S)-25-hydroxy-1-(hydroxymethyl)vitamin D3 / (1S)-25-hydroxy-1-(hydroxymethyl)cholecalciferol
(22R)-25-hydroxy-22-methoxyvitamin D3 / (22R)-25-hydroxy-22-methoxycholecalciferol
(22S)-25-hydroxy-22-methoxyvitamin D3 / (22S)-25-hydroxy-22-methoxycholecalciferol
(5Z,7E)-3,3-dimethyl-A-homo-2,4-dioxa-9,10-seco-5,7,10(19)-cholestatrien-25-ol
1α,25-dihydroxy-1β-methylvitamin D3 / 1α,25-dihydroxy-1β-methylcholecalciferol
1β,25-dihydroxy-1α-methylvitamin D3 / 1β,25-dihydroxy-1α-methylcholecalciferol
1α,25-dihydroxy-8(14)a-homovitamin D3 / 1α,25-dihydroxy-8(14)a-homocholecalciferol
2β-methyl-1α,25-dihydroxyvitamin D3 / 2β-methyl-1α,25-dihydroxycholecalciferol
(5Z,7E)-(1S,2S,3S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,2R,3S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
2α-methyl-1β,25-dihydroxyvitamin D3 / 2α-methyl-1β,25-dihydroxycholecalciferol
2β-methyl-1β,25-dihydroxyvitamin D3 / 2β-methyl-1β,25-dihydroxycholecalciferol
(5Z,7E)-(1R,2S,3S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1R,2R,3S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,2S,3R,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,2R,3R,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,2S,3S,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,2R,3S,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1R,2S,3R,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1R,2R,3R,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1R,2S,3S,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1R,2R,3S,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
1α,25-dihydroxy-11α-methylvitamin D3 / 1α,25-dihydroxy-11α-methylcholecalciferol
1α,25-dihydroxy-11β-methylvitamin D3 / 1α,25-dihydroxy-11β-methylcholecalciferol
1α,25-dihydroxy-18-methylvitamin D3 / 1α,25-dihydroxy-18-methylcholecalciferol
1α,25-dihydroxy-24a-homovitamin D3 / 1α,25-dihydroxy-24a-homocholecalciferol
(24R)-1α,25-dihydroxy-24-methylvitamin D3 /(24R)-1α,25-dihydroxy-24-methylcholecalciferol
1α,25-dihydroxy-24a-homo-20-epivitamin D3 / 1α,25-dihydroxy-24a-homo-20-epicholecalciferol
1α,25-dihydroxy-26-methylvitamin D3 / 1α,25-dihydroxy-26-methylcholecalciferol
2α-methyl-1α,25-dihydroxyvitamin D3 / 2α-methyl-1α,25-dihydroxycholecalciferol
1α,25-Dihydroxy-2E-ethylidene-19-norvitamin D3
1α,25-Dihydroxy-2Z-ethylidene-19-norvitamin D3
20(17+mm12β)-abeo-1α,25-Dihydroxy-24-dihomo-21-norvitamin D3
1,25-Dihydroxy-23-oxo-vitamin D3
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
Australigenin
Barogenin
SCHLEICHERASTATIN 6
Sintaxanthin
Schidigeragenin C
(2beta,3alpha,9alpha,24R)-Ergosta-7,22-diene-2,3,9-triol
(3beta,5beta,8beta,22E,24xi)-Ergosta-6,22-diene-3,5,8-triol
ascr#32
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (17R)-17-hydroxystearic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#32
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 18-hydroxyoctadecanoic acid (18-hydroxystearic acid) with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
(24R,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24R,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24S,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24S,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
1alpha,25-dihydroxy-18-oxovitamin D3 / 1alpha,25-dihydroxy-18-oxocholecalciferol
1alpha,25-dihydroxy-24-oxovitamin D3
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol
D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
1alpha-hydroxy-25-methoxyvitamin D3
25-methyl-1alpha,26-dihydroxyvitamin D3 / 25-methyl-1alpha,26-dihydroxycholecalciferol
(22R)-25-hydroxy-22-methoxyvitamin D3
(22S)-25-hydroxy-22-methoxyvitamin D3
25-hydroxy-3,3-dimethyl-3-deoxy-A-homo-2,4-dioxavitamin D3
1alpha,25-dihydroxy-1beta-methylvitamin D3 / 1alpha,25-dihydroxy-1beta-methylcholecalciferol
1beta,25-dihydroxy-1alpha-methylvitamin D3 / 1beta,25-dihydroxy-1alpha-methylcholecalciferol
1alpha,25-dihydroxy-8(14)a-homovitamin D3 / 1alpha,25-dihydroxy-8(14)a-homocholecalciferol
2beta-methyl-1alpha,25-dihydroxyvitamin D3 / 2beta-methyl-1alpha,25-dihydroxycholecalciferol
2alpha-methyl-3-epi-1alpha,25-dihydroxyvitamin D3 / 2alpha-methyl-3-epi-1alpha,25-dihydroxycholecalciferol
2beta-methyl-3-epi-1alpha,25-dihydroxyvitamin D3 / 2beta-methyl-3-epi-1alpha,25-dihydroxycholecalciferol
2alpha-methyl-1beta,25-dihydroxyvitamin D3 / 2alpha-methyl-1beta,25-dihydroxycholecalciferol
2beta-methyl-1beta,25-dihydroxyvitamin D3 / 2beta-methyl-1beta,25-dihydroxycholecalciferol
2alpha-methyl-3-epi-1beta,25-dihydroxyvitamin D3 / 2alpha-methyl-3-epi-1beta,25-dihydroxycholecalciferol
2beta-methyl-3-epi-1beta,25-dihydroxyvitamin D3 / 2beta-methyl-3-epi-1beta,25-dihydroxycholecalciferol
2alpha-methyl-20-epi-1alpha,25-dihydroxyvitamin D3 / 2alpha-methyl-20-epi-1alpha,25-dihydroxycholecalciferol
2beta-methyl-20-epi-1alpha,25-dihydroxyvitamin D3 / 2beta-methyl-20-epi-1alpha,25-dihydroxycholecalciferol
2alpha-methyl-20-epi-1beta,25-dihydroxyvitamin D3
2beta-methyl-20-epi-1beta,25-dihydroxyvitamin D3 / 2beta-methyl-20-epi-1beta,25-dihydroxycholecalciferol
1alpha,25-dihydroxy-11alpha-methylvitamin D3
1alpha,25-dihydroxy-11beta-methylvitamin D3
1alpha,25-dihydroxy-18-methylvitamin D3 / 1alpha,25-dihydroxy-18-methylcholecalciferol
1alpha,25-dihydroxy-24a-homovitamin D3
(24R)-1alpha,25-dihydroxy-24-methylvitamin D3 /(24R)-1alpha,25-dihydroxy-24-methylcholecalciferol
1alpha,25-dihydroxy-24a-homo-20-epivitamin D3
1alpha,25-dihydroxy-26-methylvitamin D3
2alpha-methyl-1alpha,25-dihydroxyvitamin D3 / 2alpha-methyl-1alpha,25-dihydroxycholecalciferol
1alpha,25-Dihydroxy-2E-ethylidene-19-norvitamin D3
1alpha,25-Dihydroxy-2Z-ethylidene-19-norvitamin D3
20(17->12beta)-abeo-1alpha,25-dihydroxy-24-dihomo-21-norvitamin D3
1-(4-pentylcyclohexyl)-4-[4-(4-propylcyclohexyl)phenyl]benzene
[1R-(1a,2b,3a,5a)]-5-Hydroxy-2-[(1-methoxy-1-methylethoxy)methyl]-3-[(tetrahydro-2H-pyran-2-yl)oxy]cyclopentaneheptanoic acidmethylester
Calcipotriene hydrate
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D003879 - Dermatologic Agents
2,5-Dimethyl-2,5-di-(2-ethylhexanoylperoxy) hexane
2-ethylhexyl prop-2-enoate,2-methylpropyl 2-methylprop-2-enoate,styrene
[3-(3,3-dihydroxypropoxy)-1-hydroxypropyl] (Z)-octadec-9-enoate
(EZ)-3-hydroxy-6-ethylidene-7-keto-5-cholan-24-oic acid methyl ester
24-homo-1,25-dihydroxyvitamin D3
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
12-Epi-Deoxoscalarin
A scalarane sesterterpenoid that is the deoxo derivative of 12-epi-scalarin. It has been isolated from the sponge,Hyattella species.
(1S)-1,25-dihydroxy-24-oxocalciol
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octadecanoic acid
(25R)-3beta-Hydroxycholest-5-en-7-one-26-Oic acid
A cholestanoid resulting from the oxidation of (25R)-3beta,26-dihydroxycholest-5-en-7-one to the corresponding carboxylic acid.
(17R)-17-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octadecanoic acid
(24R,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24R,25R)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24R,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24R,25S)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24S,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24S,25R)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24S,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24S,25S)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
1alpha,25-dihydroxy-18-oxovitamin D3/1alpha,25-dihydroxy-18-oxocholecalciferol
23(S),25-dihydroxy-24-oxovitamin D3
A hydroxycalciol that is 25-hydroxyvitamin D3 carrying an additional hydroxy group at position 23 (with 23S-configuration) and an oxo group at position 24. An intermediate in the degradation pathway of 25-OH-vitamin D3.
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol/(23S,25R)-25-hydroxycholecalciferol 26,23-lactol
(22E)-(24R)-1alpha,24,25-trihydroxy-22,23-didehydrovitamin D3/(22E)-(24R)-1alpha,24,25-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(24S)-1alpha,24,25-trihydroxy-22,23-didehydrovitamin D3/(22E)-(24S)-1alpha,24,25-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(25R)-1alpha,25,26-trihydroxy-22,23-didehydrovitamin D3/(22E)-(25R)-1alpha,25,26-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(25S)-1alpha,25,26-trihydroxy-22,23-didehydrovitamin D3/(22E)-(25S)-1alpha,25,26-trihydroxy-22,23-didehydrocholecalciferol
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-24-hydroxy-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenal
(1R,4S,5S,8R,9R,12R,13S,16S)-16-hydroxy-5,9,17,17-tetramethyl-8-(4-oxopentan-2-yl)-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadecan-3-one
3-Carboxylato-2-[(15-carboxy-1-oxopentadecyl)oxy]-N,N,N-trimethyl-1-propanaminium
C23H44NO6+ (430.31684640000003)
[3-Carboxy-2-(3-hydroxyheptadecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(10-hydroxyheptadecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(11-hydroxyheptadecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(12-hydroxyheptadecanoyloxy)propyl]-trimethylazanium
[3-(3,3-dihydroxypropoxy)-1-hydroxypropyl] (E)-octadec-9-enoate
(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoic acid
(8S,9S,10R,13S,17R)-17-[(2S,3R,4R,5S)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
(1R,2S,4S,7S,8R,9S,12S,13S,16S,18S)-16-Hydroxy-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-oxane]-10-one
17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid
(16R)-16-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid
(2R)-3-Carboxy-2-[(15-carboxypentadecanoyl)oxy]-N,N,N-trimethylpropan-1-aminium
C23H44NO6+ (430.31684640000003)
(6R)-6-[(7R,10R,13R,17R)-7-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid
(3S,4S,5S,10S,13R,14R,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4-carboxylic acid
Hexadecanedioic acid, bis(trimethylsilyl) ester
C22H46O4Si2 (430.29344760000004)
[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] acetate
(2alpha,8xi,9xi,14xi,16xi,17xi)-Spirost-5-en-2,3-diol
[1-carboxy-3-[2-hydroxy-3-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium
C23H44NO6+ (430.31684640000003)
[1-carboxy-3-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
C23H44NO6+ (430.31684640000003)
7alpha-hydroxy-3-oxo-4-cholestenoic acid
A cholestanoid that is cholest-4-en-26-oic acid substituted by an alpha-hydroxy group at position 7 and an oxo group at position 3. It is an intermediate metabolite in the bile acid synthesis.
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenoic acid
3beta-Hydroxy-5alpha-cholest-7-ene-4alpha-carboxylate
3beta-hydroxy-5alpha-cholest-8-ene-4alpha-carboxylic acid
A 3beta-sterol that is 5alpha-cholest-8-en-3beta-ol carrying an additional carboxy substituent at position 4alpha.
9-oxo-24-methylene-9,11-seco-cholest-5-en-3beta,11-diol
5alpha,6beta-dihydroxy-24-methylenecholestan-3-one
12beta,16beta,20R-trihydroxy-cholest-1,4-dien-3-one
3beta,5alpha,9alpha-Trihydroxycholesta-7,14-dien-6-one
5alpha,9alpha-Epidioxy-8,14alpha-epoxy-cholest-6-en-3beta-ol
4,4-diapolycopen-4-oic acid
An apo carotenoid triterpenoid that is 4,4-diapolycopene in which one of the terminal methyl groups has been replaced by a carboxy group.
(1s,3r,6r,7s,11r,13s,15r,16s)-11,13-dimethoxy-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-en-15-ol
(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,14'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-14',16'-diol
(6r,8as)-6-hydroxy-2-[(1r,2r,3r)-2-(2-hydroxyethyl)-2-methyl-3-[(2r)-6-methylheptan-2-yl]cyclopentyl]-8a-methyl-7,8-dihydro-6h-naphthalene-1,4-dione
(1r,2r,3as,3bs,9ar,9bs,11as)-2-hydroxy-1-[(2s)-7-hydroxy-6-methyl-3-oxoheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
2,16-dimethyl-15-(6-methyl-5-methylideneheptan-2-yl)-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecane-3,5-diol
7-amino-10,14,16,20-tetramethyl-23-oxa-18-azahexacyclo[12.11.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁴.0¹⁷,²²]pentacosan-22-ol
C27H46N2O2 (430.35590959999996)
5-{1-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-decahydro-2h-cyclopenta[a]phenanthren-1-yl}-5-methyloxolan-2-one
(1r,3ar,7s,8r,9ar,9bs,11ar)-7,8-dihydroxy-1-[(2r)-6-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
7,8-dihydroxy-1-(6-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-10',16'-diol
9a,11a-dimethyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-7,9,10-triol
(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,15'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-15',16'-diol
(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-5,16'-diol
(2r,4as,4br,8as,9r,10as)-2-hydroxy-4b,8,8,10a-tetramethyl-2-[(1s)-4-methyl-5-oxocyclohex-3-en-1-yl]-decahydrophenanthren-9-yl acetate
(1s,3as,3br,7s,9ar,9bs,11as)-1-[(2r,3s)-3-hydroxy-6-methyl-5-methylideneheptan-2-yl]-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-diol
1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,7,9b-triol
(1s,2r,5r,6r,9r,10r,13s,15s)-5-[(2r,5s)-5,6-dimethylheptan-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-ol
(4as,4br,6s,6as,7r,10as,10br,12as)-8-formyl-7-(hydroxymethyl)-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,7,10,10a,11,12,12a-dodecahydrochrysen-6-yl acetate
(1s,2r,5s,7s,10s,11s,14s,15r,16s,17s,20r,22s,24s)-7-amino-10,14,16,20-tetramethyl-23-oxa-18-azahexacyclo[12.11.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁴.0¹⁷,²²]pentacosan-22-ol
C27H46N2O2 (430.35590959999996)